Barely Significant
← all excerpts

Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer.

Cell Rep Med · 2025 · PMC12711678 · PMID 41172995

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Results Exposure to DEHP was associated with early tumorigenesis and low tumor infiltration of lymphocytes of human breast tumors First, we observed that tumor infiltration of CD3 + , cytotoxic CD8 + , and cytotoxic granzyme B + (GZMB + ) lymphocytes showed a trend in positive correlation with diagnosis age ( Figure S1 A), suggesting the involvement of immune dysfunction in certain populations of EOBC patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.